Table of Contents 1 Market Overview 1.1 Recombinant Human Granulocyte Colony-Stimulating Introduction 1.2 Market Analysis by Type 1.2.1 Lenograstim (Granocyte) 1.2.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) 1.2.3 Others 1.3 Market Analysis by Applications 1.3.1 Chemotherapy Induced Neutropenia 1.3.2 Before Blood Donation 1.3.3 Stem Cell Transplants 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Amgen 2.1.1 Business Overview 2.1.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Huaxin 2.2.1 Business Overview 2.2.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Kyowa Hakko Kirin 2.3.1 Business Overview 2.3.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Qilu Pharmaceutical 2.4.1 Business Overview 2.4.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Hangzhou Jiuyuan 2.5.1 Business Overview 2.5.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Shijiazhuang Pharmaceutical 2.6.1 Business Overview 2.6.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Sinovac 2.7.1 Business Overview 2.7.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Amoytop Biotech 2.8.1 Business Overview 2.8.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Gensci 2.9.1 Business Overview 2.9.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Triprime 2.10.1 Business Overview 2.10.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Zhaoke 2.11.1 Business Overview 2.11.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Kawin 2.12.1 Business Overview 2.12.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share in 2018 3.3.2 Top 6 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Recombinant Human Granulocyte Colony-Stimulating Market Analysis by Regions 4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Regions 4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Regions (2014-2019) 4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Regions (2014-2019) 4.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 4.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 4.5 South America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 5 North America Recombinant Human Granulocyte Colony-Stimulating by Country 5.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country 5.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019) 5.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019) 5.2 United States Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 5.3 Canada Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 5.4 Mexico Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 6 Europe Recombinant Human Granulocyte Colony-Stimulating by Country 6.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country 6.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019) 6.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019) 6.2 Germany Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 6.3 UK Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 6.4 France Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 6.5 Russia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 6.6 Italy Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 7 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating by Country 7.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019) 7.2 China Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 7.3 Japan Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 7.4 Korea Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 7.5 India Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 8 South America Recombinant Human Granulocyte Colony-Stimulating by Country 8.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country 8.1.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019) 8.1.2 South America Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019) 8.2 Brazil Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 8.3 Argentina Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 8.4 Colombia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 9 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Countries 9.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 9.3 Turkey Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 9.4 Egypt Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 9.5 Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 9.6 South Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) 10 Global Recombinant Human Granulocyte Colony-Stimulating Market Segment by Type 10.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Type (2014-2019) 10.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Type (2014-2019) 10.2 Lenograstim (Granocyte) Sales Growth and Price 10.2.1 Global Lenograstim (Granocyte) Sales Growth (2014-2019) 10.2.2 Global Lenograstim (Granocyte) Price (2014-2019) 10.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Sales Growth and Price 10.3.1 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Sales Growth (2014-2019) 10.3.2 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Price (2014-2019) 10.4 Others Sales Growth and Price 10.4.1 Global Others Sales Growth (2014-2019) 10.4.2 Global Others Price (2014-2019) 11 Global Recombinant Human Granulocyte Colony-Stimulating Market Segment by Application 11.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019) 11.2 Chemotherapy Induced Neutropenia Sales Growth (2014-2019) 11.3 Before Blood Donation Sales Growth (2014-2019) 11.4 Stem Cell Transplants Sales Growth (2014-2019) 11.5 Others Sales Growth (2014-2019) 12 Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Growth Rate (2019-2024) 12.2 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Regions (2019-2024) 12.2.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.2.3 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.2.4 South America Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.2.5 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) 12.3 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Type (2019-2024) 12.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2019-2024) 12.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Type (2019-2024) 12.4 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Application (2019-2024) 12.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2019-2024) 12.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Recombinant Human Granulocyte Colony-Stimulating Picture Table Product Specifications of Recombinant Human Granulocyte Colony-Stimulating Figure Global Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Types in 2018 Table Recombinant Human Granulocyte Colony-Stimulating Types for Major Manufacturers Figure Lenograstim (Granocyte) Picture Figure Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Picture Figure Others Picture Figure Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Applications in 2018 Figure Chemotherapy Induced Neutropenia Picture Figure Before Blood Donation Picture Figure Stem Cell Transplants Picture Figure Others Picture Figure United States Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Canada Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Germany Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure France Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure UK Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Russia Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Italy Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure China Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Japan Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Korea Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure India Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Egypt Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Revenue (Value) and Growth Rate (2014-2024) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Huaxin Basic Information, Manufacturing Base and Competitors Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Hangzhou Jiuyuan Basic Information, Manufacturing Base and Competitors Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Shijiazhuang Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Sinovac Basic Information, Manufacturing Base and Competitors Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Amoytop Biotech Basic Information, Manufacturing Base and Competitors Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Gensci Basic Information, Manufacturing Base and Competitors Table Gensci Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Triprime Basic Information, Manufacturing Base and Competitors Table Triprime Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Zhaoke Basic Information, Manufacturing Base and Competitors Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Kawin Basic Information, Manufacturing Base and Competitors Table Kawin Recombinant Human Granulocyte Colony-Stimulating Type and Applications Table Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturer (2017-2018) Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturer in 2017 Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturer in 2018 Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturer (2017-2018) Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturer in 2017 Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturer in 2018 Figure Top 3 Recombinant Human Granulocyte Colony-Stimulating Manufacturer (Revenue) Market Share in 2018 Figure Top 6 Recombinant Human Granulocyte Colony-Stimulating Manufacturer (Revenue) Market Share in 2018 Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Regions (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Regions (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Regions (2014-2019) Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions (2014-2019) Figure Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions in 2018 Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Europe Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure South America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure North America Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table North America Recombinant Human Granulocyte Colony-Stimulating Sales by Countries (2014-2019) Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries in 2018 Table North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Countries (2014-2019) Table North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries in 2018 Figure United States Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Canada Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Europe Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Countries (2014-2019) Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Table Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Countries (2014-2019) Figure Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries in 2018 Figure Germany Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure UK Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure France Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Russia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Italy Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Countries (2014-2019) Table Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Figure Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries 2018 Table Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Countries (2014-2019) Figure Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries 2018 Figure China Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Japan Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Korea Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure India Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure South America Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table South America Recombinant Human Granulocyte Colony-Stimulating Sales by Countries (2014-2019) Table South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Figure South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries in 2018 Table South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Countries (2014-2019) Table South America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure South America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries in 2018 Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Argentina Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Colombia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2014-2019) Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Countries (2014-2019) Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries (2014-2019) Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Countries in 2018 Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Countries (2014-2019) Table Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Countries in 2018 Figure Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure UAE Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Egypt Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2014-2019) Figure Global Lenograstim (Granocyte) Sales Growth (2014-2019) Figure Global Lenograstim (Granocyte) Price (2014-2019) Figure Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Sales Growth (2014-2019) Figure Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Price (2014-2019) Figure Global Others Sales Growth (2014-2019) Figure Global Others Price (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2014-2019) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2014-2019) Figure Global Chemotherapy Induced Neutropenia Sales Growth (2014-2019) Figure Global Before Blood Donation Sales Growth (2014-2019) Figure Global Stem Cell Transplants Sales Growth (2014-2019) Figure Global Others Sales Growth (2014-2019) Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Growth Rate (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Regions (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Regions (2019-2024) Figure North America Sales Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) Figure Europe Sales Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) Figure Asia-Pacific Sales Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) Figure South America Sales Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) Figure Middle East and Africa Sales Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Type (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2019-2024) Table Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Application (2019-2024) Table Distributors/Traders/ Dealers List

Amgen Huaxin Kyowa Hakko Kirin Qilu Pharmaceutical Hangzhou Jiuyuan Shijiazhuang Pharmaceutical Sinovac Amoytop Biotech Gensci Triprime Zhaoke Kawin